ADMA

ADMA Biologics Inc (ADMA)

About ADMA Biologics Inc (ADMA)

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Details

Daily high
$20.58
Daily low
$19.71
Price at open
$19.89
52 Week High
$20.58
52 Week Low
$3.06
Market cap
4.7B
Dividend yield
0.00%
Volume
4.2M
Avg. volume
7.4M
P/E ratio
144.31

ADMA Biologics Inc News

Details

Daily high
$20.58
Daily low
$19.71
Price at open
$19.89
52 Week High
$20.58
52 Week Low
$3.06
Market cap
4.7B
Dividend yield
0.00%
Volume
4.2M
Avg. volume
7.4M
P/E ratio
144.31